Form: SCHEDULE 13G

Statement of Beneficial Ownership by Certain Investors

May 15, 2026

EXHIBIT 99.1


JOINT FILING STATEMENT


We, the undersigned, hereby express our agreement that the attached statement on Schedule 13G relating to the common stock of Sutro Biopharma, Inc. is filed on behalf of each of us.


Dated:  May 15, 2026


Samsara BioCapital, L.P.


By:

Samsara BioCapital GP, LLC

Its:

General Partner


By:

/s/ Srinivas Akkaraju

Name: Srinivas Akkaraju

Title: Managing Member

Samsara BioCapital GP, LLC


By:

/s/ Srinivas Akkaraju

Name: Srinivas Akkaraju

Title: Managing Member


Samsara Opportunity Fund, L.P.


By:

Samsara Opportunity Fund GP, LLC

Its:

General Partner


By:

/s/ Srinivas Akkaraju

Name: Srinivas Akkaraju

Title: Managing Member

Samsara Opportunity Fund GP, LLC


By:

/s/ Srinivas Akkaraju

Name: Srinivas Akkaraju

Title: Managing Member



/s/ Srinivas Akkaraju

Srinivas Akkaraju